Sex Differences in Metabolic Syndrome and Type 2 Diabetes in Canada
A 2024 Canadian study using health records from over 37,000 adults shows that metabolic syndrome (MetS), a key driver of heart disease and often linked to type 2 diabetes (T2D), affects men and women differently.
Women generally had a lower risk than men, but risk was higher in women taking antidepressants. Social deprivation also played a role, with women experiencing higher social disadvantage.
Understanding these sex- and gender-specific risk factors can help tailor prevention and treatment strategies for MetS and T2D to reduce cardiovascular disease in Canadians.
2 Views
